A recently conducted clinical trial has revealed that a revolutionary drug, known as Compound X, shows significant results in the treatment of Alzheimer's disease. The study, which involved a large number of patients, https://www.worldpharmatoday.com/press-releases/datma-launches-federated-biomarker-explorer-with-free-access-to-help-pharma-validate-real-world-data-coverage/